Skip navigation
Home
Browse
Communities
& Collections
Browse Items by:
Issue Date
Author
Title
Advisor
Help
Sign on to:
My DSpace
Receive email
updates
Edit Profile
Adelaide Research & Scholarship
Adelaide Research & Scholarship
Browsing "Schools and Disciplines" by Author Eadie, L.
Jump to:
0-9
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
or enter first few letters:
Sort by:
title
issue date
submit date
In order:
Ascending
Descending
Results/Page
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Authors/Record:
All
1
5
10
15
20
25
30
35
40
45
50
Showing results 1 to 10 of 10
Preview
Issue Date
Title
Author(s)
2016
ABCB1 Overexpression Is a key initiator of resistance to tyrosine kinase inhibitors in CML cell lines
Eadie, L.
;
Hughes, T.
;
White, D.
;
Eaves, C.
2016
ABCB1 overexpression predicts outcome of CML patients undergoing first-line imatinib treatment
Eadie, L.
;
Hughes, T.
;
White, D.
;
New Directions in Leukaemia Research 2016 Meeting (NDLR) (16 Mar 2016 - 19 Mar 2016 : Noosa, QLD)
2018
ABCC6 plays a significant role in the transport of nilotinib and dasatinib, and contributes to TKI resistance in vitro, in both cell lines and primary patient mononuclear cells
Eadie, L.
;
Dang, P.
;
Goyne, J.
;
Hughes, T.
;
White, D.
;
Maga, G.
2008
Dasatinib cellular uptake and efflux in chronic myeloid leukemia cells: therapeutic implications
Hiwase, D.
;
Saunders, V.
;
Hewett, D.
;
Frede, A.
;
Zrim, S.
;
Dang, P.
;
Eadie, L.
;
To, L.
;
Vaz de Melo, J.
;
Kumar, S.
;
Hughes, T.
;
White, D.
2013
Degree of kinase inhibition achieved in vitro by imatinib and nilotinib is decreased by high levels of ABCB1 but not ABCG2
Eadie, L.
;
Saunders, V.
;
Hughes, T.
;
White, D.
2019
High risk genomic alterations identified at the time of diagnosis are strongly associated with MRD and subsequent poor outcomes in AYA ALL patients treated on a pediatric inspired chemotherapy regimen
Yeung, D.
;
Greenwood, M.
;
Rehn, J.
;
Heatley, S.
;
McClure, B.
;
Eadie, L.
;
Breen, J.
;
Schutz, C.
;
Trahair, T.
;
Wei, A.
;
Dalla-Pozza, L.
;
Sutton, R.
;
Bradstock, K.
;
Osborn, M.
;
White, D.
;
American Society of Hematology Annual Meeting (ASH) (7 Dec 2019 - 10 Dec 2019 : Orlando, CA)
2014
Interaction of the efflux transporters ABCB1 and ABCG2 with imatinib, nilotinib, and dasatinib
Eadie, L.
;
Hughes, T.
;
White, D.
2005
Microsatellite (SSR) diversity among Australian Rhynchosporium secalis isolates
Keiper, F.
;
Scott, L.
;
Eadie, L.
;
Hayden, M.
;
Wallwork, H.
;
Australian Barley Technical Symposium (12th : 2005 : Hobart, Tasmania)
2010
Nilotinib does not significantly reduce imatinib OCT-1 activity in either cell lines or primary CML cells
Eadie, L.
;
Hughes, T.
;
White, D.
2013
Proton pump inhibitors significantly increase the intracellular concentration of nilotinib, but not imatinib in target CML cells
White, D.
;
Eadie, L.
;
Saunders, V.
;
Hiwase, D.
;
Hughes, T.